ama-0076
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2012 (NCT01693315)
Timeline
Indications
Mechanism of action
- Rho-associated protein kinaseINHIBITOR
Rho-associated protein kinase inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3545073 ↗
Also known as
- ama0076
- ama0076
- ama-0076
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02136940 | Phase 2 | Apr 1, 2014 | Amakem, NV |
| NCT02003547 | Phase 1 | Sep 1, 2013 | Amakem, NV, Quotient |
| NCT01693315 | Phase 2 | Sep 1, 2012 | Amakem, NV |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Amakem, NV | For profit | 3 | 3 | 2 | 2012 |
| Quotient | For profit | 1 | 0 | 1 | 2013 |
2 organizations
Page 1 / 1